Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
- PMID: 8383597
- DOI: 10.1016/0920-1211(93)90070-n
Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
Abstract
3-Isobutyl GABA is a derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and is also structurally related to the novel anticonvulsant gabapentin. The S(+) enantiomer of 3-isobutyl GABA blocks maximal electroshock seizures in mice and also potently displaces tritiated gabapentin from a novel high-affinity binding site in rat brain membrane fractions. The R(-) enantiomer is much less active in both assays, suggesting that the gabapentin binding site is involved in the anticonvulsant activity of 3-isobutyl GABA.
Similar articles
-
Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.Eur J Pharmacol. 1993 Feb 15;244(3):293-301. doi: 10.1016/0922-4106(93)90155-3. Eur J Pharmacol. 1993. PMID: 8384570
-
The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat.Anesth Analg. 1998 Feb;86(2):348-54. doi: 10.1097/00000539-199802000-00025. Anesth Analg. 1998. PMID: 9459247
-
The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors.Mol Pharmacol. 2002 Jun;61(6):1377-84. doi: 10.1124/mol.61.6.1377. Mol Pharmacol. 2002. PMID: 12021399
-
3-substituted GABA analogs with central nervous system activity: a review.Med Res Rev. 1999 Mar;19(2):149-77. doi: 10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b. Med Res Rev. 1999. PMID: 10189176 Review.
-
Mechanisms of action of gabapentin.Rev Neurol (Paris). 1997;153 Suppl 1:S39-45. Rev Neurol (Paris). 1997. PMID: 9686247 Review.
Cited by
-
Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effects.ACS Chem Neurosci. 2014 Jul 16;5(7):525-32. doi: 10.1021/cn500053d. Epub 2014 Apr 30. ACS Chem Neurosci. 2014. PMID: 24738473 Free PMC article.
-
Primary amines protect against retinal degeneration in mouse models of retinopathies.Nat Chem Biol. 2011 Dec 25;8(2):170-8. doi: 10.1038/nchembio.759. Nat Chem Biol. 2011. PMID: 22198730 Free PMC article.
-
Mixed effects modeling of weight change associated with placebo and pregabalin administration.J Pharmacokinet Pharmacodyn. 2007 Dec;34(6):753-70. doi: 10.1007/s10928-007-9067-z. Epub 2007 Aug 10. J Pharmacokinet Pharmacodyn. 2007. PMID: 17690866
-
Antiallodynic effect of pregabalin in rat models of sympathetically maintained and sympathetic independent neuropathic pain.Yonsei Med J. 2007 Feb 28;48(1):41-7. doi: 10.3349/ymj.2007.48.1.41. Yonsei Med J. 2007. PMID: 17326244 Free PMC article.
-
New Horizons in the development of antiepileptic drugs: Innovative strategies.Epilepsy Res. 2006 Jun;69(3):183-272. doi: 10.1016/j.eplepsyres.2006.03.014. Epilepsy Res. 2006. PMID: 16835945 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources